BlueCrest Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,109
Closed -$419K – 244
2023
Q4
$374K Sell
1,109
-833
-43% -$248K 0.01% 204
2023
Q3
$568K Buy
+1,942
New +$606K 0.03% 202
2018
Q4
– Sell
-2,979
Closed -$570K – 1141
2018
Q3
$570K Sell
2,979
-60,603
-95% -$10.8M 0.02% 683
2018
Q2
$10.1M Buy
63,582
+60,819
+2,201% +$9.27M 0.26% 74
2018
Q1
$380K Buy
+2,763
New +$386K 0.01% 913
2017
Q2
– Sell
-3,933
Closed -$335K – 1000
2017
Q1
$335K Buy
+3,933
New +$311K 0.02% 504
2016
Q4
– Sell
-6,282
Closed -$506K – 766
2016
Q3
$506K Buy
+6,282
New +$481K 0.02% 525
2016
Q1
– Sell
-21,069
Closed -$1.28M – 948
2015
Q4
$1.28M Buy
21,069
+14,715
+232% +$826K 0.05% 343
2015
Q3
$324K Buy
6,354
+981
+18% +$55.6K 0.01% 685
2015
Q2
$289K Buy
+5,373
New +$301K 0.01% 715

Other funds holding ISRG

BlueCrest Capital Management's ISRG Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Intuitive Surgical (ISRG) in Q1 2024, closing a stake of 1,109 shares — an estimated $419K sold.

BlueCrest Capital Management first reported a position in ISRG in Q2 2015 and held it in 10 quarters. The position peaked at $10.1M in Q2 2018. 1,745 funds tracked by Wall St. Rank hold ISRG as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Intuitive Surgical position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,109 Intuitive Surgical shares in Q1 2024, an estimated $419K.
  • BlueCrest Capital Management first reported a position in Intuitive Surgical in Q2 2015 and held it in 10 quarters.
  • BlueCrest Capital Management's Intuitive Surgical position peaked at $10.1M in Q2 2018.
  • 1,745 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.